切换至 "中华医学电子期刊资源库"

中华老年骨科与康复电子杂志 ›› 2022, Vol. 08 ›› Issue (06) : 345 -349. doi: 10.3877/cma.j.issn.2096-0263.2022.06.005

髋部骨折

股骨近端防旋髓内钉治疗绝经后妇女股骨转子间骨折的疗效分析
王苗1, 孙健1, 林彬辉1, 王宏杰1, 孙卫兵1,()   
  1. 1. 201803 上海市第一人民医院嘉定分院/嘉定区江桥医院骨科
  • 收稿日期:2022-09-22 出版日期:2022-12-05
  • 通信作者: 孙卫兵
  • 基金资助:
    上海市嘉定区科学基金(JDKW-2021-0013)

Analysis of the effect of proximal femoral nail antirotation technology in the treatment of femoral intertrochanteric fractures in postmenopausal women

Miao Wang1, Jian Sun1, BinHui Lin1, HongJie Wang1, WeiBing Sun1,()   

  1. 1. Department of Orthopaedics, Jiading Branch of Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 201803, China
  • Received:2022-09-22 Published:2022-12-05
  • Corresponding author: WeiBing Sun
引用本文:

王苗, 孙健, 林彬辉, 王宏杰, 孙卫兵. 股骨近端防旋髓内钉治疗绝经后妇女股骨转子间骨折的疗效分析[J]. 中华老年骨科与康复电子杂志, 2022, 08(06): 345-349.

Miao Wang, Jian Sun, BinHui Lin, HongJie Wang, WeiBing Sun. Analysis of the effect of proximal femoral nail antirotation technology in the treatment of femoral intertrochanteric fractures in postmenopausal women[J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2022, 08(06): 345-349.

目的

探讨股骨近端防旋髓内钉技术(PFNA)治疗绝经后妇女转子间骨折的疗效。

方法

回顾性分析2020年12月至2021年10月在本科进行PFNA手术治疗的40例绝经期女性患者,年龄49~86岁,平均(67.3±11.2)岁,使用Harris髋关节功能评分、疼痛视觉模拟评分(VAS)以及健康调查简表(SF36)进行疗效评估。

结果

40例患者获得完整随访,随访时间9~12月,平均(11±1)个月。末次随访时,Harris评分及SF36评分分别较术前提高(72.8±11)分、(55.7±11.5)分,VAS评分较术前下降(5.9±2.1)分(P<0.05)。

结论

PFNA术用于绝经后妇女的股骨转子间骨折的治疗效果良好。

Objective

To investigate the therapeutic effect of proximal femoral nail antirotation (PFNA) technique for intertrochanteric fractures in postmenopausal women.

Methods

From December 2020 to October 2021, 40 postmenopausal female patients who underwent PFNA surgery in our department were retrospectively analyzed. Harris hip function score, visual analog scale (VAS) and the MOS item short from health survey (SF36) score were used to evaluate the curative effect.

Results

All patients were followed up after operation to 9 months. At the last follow-up, the Harris score and SF36 score were higher than those before operation, and the VAS score was lower than that before operation, and the differences were statistically significant (P<0.05).

Conclusions

PFNA is used for the treatment of femoral intertrochanteric fractures in postmenopausal women, and the postoperative satisfaction is high and the effect is good.

表1 40例行PFNA治疗的绝经后女性患者手术前后髋关节功能评分(分,±s
图5~6 78岁女性,骨折分型为EvansII型骨折,骨折线累及大粗隆
1
Zuo J, Hu Y. Admission deep venous thrombosis of lower extremity after intertrochanteric fracture in the elderly: a retrospective cohort study [J]. J Orthop Surg Res, 2020, 15(1): 549.
2
Lu W, Zhu W, Xiao Y, et al. The clinical efficacy of Shengyu decoction in the treatment of anemia after PFNA for elderly intertrochanteric fracture: A protocol of prospective,randomized,controlled trial [J]. Medicine, 2022, 101(6): e28812.
3
Jiang W, Shang L. Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery:A meta-analysis [J]. Medicine, 2019, 98(11): e14564.
4
Wang T, Guo J, Hou Z. Risk factors for perioperative hidden blood loss after intertrochanteric fracture surgery in Chinese patients:a Meta-Analysis [J]. 2022: 13.
5
Ekinci Y, Gurbuz K, Batin S, et al. A multicenter intertrochanteric fracture study in the elderly:Hemiarthroplasty versus proximal femoral nailing [J]. Jt Dis Relat Surg, 2020, 31(2): 209-217.
6
Cheng YX, Sheng X. Optimal surgical methods to treat intertrochanteric fracture: a Bayesian network meta-analysis based on 36 randomized controlled trials [J]. J Orthop Surg Res, 2020, 15(1): 402.
7
Christensen H, Cordonnier C. Age At Menopause: A Female Risk Factor of Stroke? Stroke, 2021, 52(8): 2592-3.
8
Conde DM, Verdade RC, Valadares A, et al. Menopause and cognitive impairment:A narrative review of current knowledge [J]. World J Psychiatry, 2021, 11(8): 412-428.
9
Zhuang HF, Wang PW, Li YZ, et al. Analysis of related factors of brittle hip fracture in postmenopausal women with osteoporosis [J]. Orthop Surg, 2020, 12(1): 194-198.
10
Booyens RM, Engelbrecht AM, Strauss L, et al. To clot, or not to clot: The dilemma of hormone treatment options for menopause [J]. Thromb Res, 2022, 218: 99-111.
11
Fu YC, Liu R, Liu Y, et al. Intertrochanteric fracture visualization and analysis using a map projection technique [J]. Med Biol Eng Comput, 2019, 57(3): 633-642.
12
Wang PW, Li YZ, Zhuang HF, et al. Anti-Osteoporosis medications associated with decreased mortality after hip fracture [J]. Orthop Surg, 2019, 11(5): 777-783.
13
Kani KK, Porrino JA, Mulcahy H, et al. Fragility fractures of the proximal femur: review and update for radiologists [J]. Skeletal Radiol, 2019, 48(1): 29-45.
14
Dung TT, Hieu ND, Son LM, et al. Primary cementless bipolar long stem hemiarthroplasty for unstable osteoporotic intertrochanteric fracture in the elderly patients [J]. Open Access Maced J Med Sci, 2019, 7(24): 4342-4346.
15
Ucpunar H, Camurcu Y, Cobden A, Sofu H, Kis M, Demirel H. Comparative evaluation of postoperative health status and functional outcome in patients treated with either proximal femoral nail or hemiarthroplasty for unstable intertrochanteric fracture [J]. J Orthop Surg (Hong Kong), 2019, 27(3): 2309499019864426.
16
Li XP, Zhang P, Zhu SW, et al. All-cause mortality risk in aged femoral intertrochanteric fracture patients [J]. J Orthop Surg Res, 2021, 16(1): 727.
17
Sun X, Guo Q, Wei W, et al. Current progress on MicroRNA-Based gene delivery in the treatment of osteoporosis and osteoporotic fracture [J]. Int J Endocrinol, 2019: 6782653.
18
Lee Y, Ogihara N, Lee T. Assessment of finite element models for prediction of osteoporotic fracture [J]. J Mech Behav Biomed Mater, 2019, 97: 312-20.
19
Yu J, Zhang C, Li L, et al. Internal fixation treatments for intertrochanteric fracture:a systematic review and meta-analysis of randomized evidence [J]. Sci Rep, 2015: 18195.
20
Huang G, Zhang M, Qu Z, et al. Fixation options for Reconstruction of the greater trochanter in unstable intertrochanteric fracture with arthroplasty [J]. Medicine, 2021, 100(26): e26395.
21
Ren HR, Ao RG, Wu LH, et al. Effect of lesser trochanter posteromedial wall defect on the stability of femoral intertrochanteric fracture using 3D simulation [J]. J Orthop Surg Res, 2020, 15(1): 242.
22
Zhao K, Zhang J, Li J, et al. Incidence of and risk factors for new-onset deep venous thrombosis after intertrochanteric fracture surgery [J]. Sci Rep, 2021, 11(1): 17319.
23
Zhu WH, Yan YJ, Sun YJ, et al. Implementation of enhanced recovery after surgery (ERAS) protocol for elderly patients receiving surgery for intertrochanteric fracture: a propensity score-matched analysis [J]. J Orthop Surg Res, 2021, 16(1): 469.
24
Wei H, Xiao Q, He J, et al. Effect and safety of topical application of tranexamic acid to reduce perioperative blood loss in elderly patients with intertrochanteric fracture undergoing PFNA [J]. Medicine, 2021, 100(34): e27123.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[3] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[4] 中华医学会骨科学分会关节外科学组, 广东省医学会骨质疏松和骨矿盐疾病分会, 广东省佛山市顺德区第三人民医院. 中国髋部脆性骨折术后抗骨质疏松药物临床干预指南(2023年版)[J]. 中华关节外科杂志(电子版), 2023, 17(06): 751-764.
[5] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[6] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[7] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[8] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[9] 孔博, 张璟, 吕珂. 超声技术在复杂腹壁疝诊治中的作用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 670-673.
[10] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[11] 杨瑞洲, 李国栋, 吴向阳. 腹股沟疝术后感染的治疗方法探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 715-719.
[12] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要